These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 33669653)

  • 21. Pseudomonas aeruginosa Antivirulence Strategies: Targeting the Type III Secretion System.
    Goldberg JB; Crisan CV; Luu JM
    Adv Exp Med Biol; 2022; 1386():257-280. PubMed ID: 36258075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and biophysics of type III secretion in bacteria.
    Chatterjee S; Chaudhury S; McShan AC; Kaur K; De Guzman RN
    Biochemistry; 2013 Apr; 52(15):2508-17. PubMed ID: 23521714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel T3SS effector EseK in Edwardsiella piscicida is chaperoned by EscH and EscS to express virulence.
    Cao H; Yang C; Quan S; Hu T; Zhang L; Zhang Y; Yang D; Liu Q
    Cell Microbiol; 2018 Jan; 20(1):. PubMed ID: 29024267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SrcA is a chaperone for the Salmonella SPI-2 type three secretion system effector SteD.
    Godlee C; Cerny O; Durkin CH; Holden DW
    Microbiology (Reading); 2019 Jan; 165(1):15-25. PubMed ID: 30457515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Export via the Type III Secretion System of the Bacterial Flagellum.
    Halte M; Erhardt M
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shutting Down Shigella Secretion: Characterizing Small Molecule Type Three Secretion System ATPase Inhibitors.
    Case HB; Mattock DS; Dickenson NE
    Biochemistry; 2018 Dec; 57(50):6906-6916. PubMed ID: 30460850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural analysis of ligand-bound states of the Salmonella type III secretion system ATPase InvC.
    Bernal I; Römermann J; Flacht L; Lunelli M; Uetrecht C; Kolbe M
    Protein Sci; 2019 Oct; 28(10):1888-1901. PubMed ID: 31393998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vibrio parahaemolyticus Senses Intracellular K
    Tandhavanant S; Matsuda S; Hiyoshi H; Iida T; Kodama T
    mBio; 2018 Jul; 9(4):. PubMed ID: 30042203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chaperone-mediated secretion switching from early to middle substrates in the type III secretion system encoded by
    Takaya A; Takeda H; Tashiro S; Kawashima H; Yamamoto T
    J Biol Chem; 2019 Mar; 294(10):3783-3793. PubMed ID: 30651351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of autocleavage in the function of a type III secretion specificity switch protein in Salmonella enterica serovar Typhimurium.
    Monjarás Feria JV; Lefebre MD; Stierhof YD; Galán JE; Wagner S
    mBio; 2015 Oct; 6(5):e01459-15. PubMed ID: 26463164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering the pain: an overview of the type III secretion system with special consideration for aquatic pathogens.
    Rahmatelahi H; El-Matbouli M; Menanteau-Ledouble S
    Vet Res; 2021 Dec; 52(1):146. PubMed ID: 34924019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins.
    Tejeda-Dominguez F; Huerta-Cantillo J; Chavez-Dueñas L; Navarro-Garcia F
    mBio; 2017 Mar; 8(2):. PubMed ID: 28351918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional dissection of translocon proteins of the Salmonella pathogenicity island 2-encoded type III secretion system.
    Hölzer SU; Hensel M
    BMC Microbiol; 2010 Apr; 10():104. PubMed ID: 20377892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Swiss Army Pathogen: The
    Hume PJ; Singh V; Davidson AC; Koronakis V
    Front Cell Infect Microbiol; 2017; 7():348. PubMed ID: 28848711
    [No Abstract]   [Full Text] [Related]  

  • 36. Type III Secretion in the Melioidosis Pathogen
    Vander Broek CW; Stevens JM
    Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
    [No Abstract]   [Full Text] [Related]  

  • 37. Interfacial amino acids support Spa47 oligomerization and shigella type three secretion system activation.
    Demler HJ; Case HB; Morales Y; Bernard AR; Johnson SJ; Dickenson NE
    Proteins; 2019 Nov; 87(11):931-942. PubMed ID: 31162724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensing for survival: specialised regulatory mechanisms of Type III secretion systems in Gram-negative pathogens.
    Manisha Y; Srinivasan M; Jobichen C; Rosenshine I; Sivaraman J
    Biol Rev Camb Philos Soc; 2024 Jun; 99(3):837-863. PubMed ID: 38217090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conserved Salt Bridges Facilitate Assembly of the Helical Core Export Apparatus of a Salmonella enterica Type III Secretion System.
    Singh N; Kronenberger T; Eipper A; Weichel F; Franz-Wachtel M; Macek B; Wagner S
    J Mol Biol; 2021 Sep; 433(19):167175. PubMed ID: 34303721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.
    Lam H; Schwochert J; Lao Y; Lau T; Lloyd C; Luu J; Kooner O; Morgan J; Lokey S; Auerbuch V
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.